![Mary Harler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mary Beth Harler formerly worked at IGM Biosciences, Inc., as Chief Executive Officer & Director from 2024 to 2025 and Bristol Myers Squibb Co., as SVP, Head-Immunology & Fibrosis Development.
Dr. Harler received her doctorate degree from Marshall University and undergraduate degree from Wheeling University.
Eerdere bekende functies van Mary Harler
| Bedrijven | Functie | Einde |
|---|---|---|
| IGM BIOSCIENCES, INC. | Algemeen Directeur | 14-08-2025 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Mary Harler
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Marshall University
 Marshall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
